UNI-MB - logo
UMNIK - logo
 
Narodna in univerzitetna knjižnica, Ljubljana (NUK)
Naročanje gradiva za izposojo na dom
Naročanje gradiva za izposojo v čitalnice
Naročanje kopij člankov
Urnik dostave gradiva z oznako DS v signaturi
  • Systemic treatment of colon cancer
    Štabuc, Borut
    Colorectal cancer (CRC) is a second only to lung cancer as a leading cause of death from cancer. CRC alone accounts for around 200,000 deaths in Europe and represents a significant health problem. ... Although about fifty percent of patients are cured by surgery alone, the other half will eventually die due tometastatic disease, which includes approximately 25% of patients who have evidence of metastases at the time of diagnosis. Surgical resection of the primary tumor and regional lymph nodes is the only curative therapy for CRC. However, adjuvant chemotherapy in stage III. colon cancer following curative resection has been shown to reduce the risk of recurrence by 19-40% and of death by 16-33%. 5-fluorouracil and leucovorin given for six months may represent the best adjuvant treatment available today. The contribution of levamisole to adjuvant treatment seems to be marginal, if any. The benefit of adjuvant chemotherapy for the patients with Dukes B colon cancer is less clear.
    Vir: Gastroenterolog : revija Slovenskega združenja za gastroenterologijo in hepatologijo = journal of Slovenian Association for Gastroenterology and Hepatology. - ISSN 1408-2756 (Letn. 8, supl. 2, okt. 2004, str. 277-286)
    Vrsta gradiva - prispevek na konferenci
    Leto - 2004
    Jezik - angleški
    COBISS.SI-ID - 18698713

Vnos na polico